Literature DB >> 7875175

Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide [1].

L Maffioli, A Chiti, M Gasparini, E Bombardieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7875175     DOI： 10.1007/bf02426702

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


× No keyword cloud information.
  8 in total

1.  Increases in mortality from cutaneous melanoma in southern Europe.

Authors:  S Franceschi; C La Vecchia; E Negri; F Levi
Journal:  Int J Cancer       Date:  1992-04-22       Impact factor: 7.396

2.  Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide.

Authors:  C A Hoefnagel; E M Rankin; R A Valdés Olmos; S P Israëls; S Pavel; A G Janssen
Journal:  Eur J Nucl Med       Date:  1994-06

3.  Immunoscintigraphy with 123I, 99mTc and 111In-labelled F(ab')2 fragments of monoclonal antibodies to a human high molecular weight-melanoma associated antigen.

Authors:  G L Buraggi; L Callegaro; A Turrin; N Cascinelli; A Attili; H Emanuelli; M Gasparini; G Deleide; G Plassio; M Dovis
Journal:  J Nucl Med Allied Sci       Date:  1984 Oct-Dec

4.  European multicentre study on melanoma immunoscintigraphy by means of 99mTc-labelled monoclonal antibody fragments. The European Multicentre Study Group.

Authors:  A G Siccardi; G L Buraggi; P G Natali; G A Scassellati; G Viale; S Ferrone
Journal:  Eur J Nucl Med       Date:  1990

5.  Cancer in the European Community and its member states.

Authors:  O M Jensen; J Estève; H Møller; H Renard
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

6.  Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM).

Authors:  L Maffioli; L Mascheroni; V Mongioj; M Gasparini; M T Baldini; E Seregni; M R Castellani; N Cascinelli; G L Buraggi
Journal:  J Nucl Med       Date:  1994-11       Impact factor: 10.057

7.  Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.

Authors:  G L Buraggi; L Callegaro; G Mariani; A Turrin; N Cascinelli; A Attili; E Bombardieri; G Terno; G Plassio; M Dovis
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

8.  Progress in the fight against cancer in EC countries: changes in mortality rates, 1970-90.

Authors:  M Geddes; D Balzi; L Tomatis
Journal:  Eur J Cancer Prev       Date:  1994-01       Impact factor: 2.497
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.